HDAC9 and neoplasm: Although our data supports RT with the immunosuppressive responses such as upregulated expression of PD-L1 by tumor cells (6), the combined HDAC inhibition may reverse the immunosuppressive effect of RT by revitalizing NK cells and/or cytotoxic T cells to maximize the therapeutic effect.